Publication | Closed Access
High drug prices are not justified by industry’s spending on research and development
48
Citations
25
References
2023
Year
Aris Angelis and colleagues argue that by refocusing their spending drug companies could provide more innovative drugs at affordable prices
| Year | Citations | |
|---|---|---|
Page 1
Page 1